Why is RVMD down?
Down 3% on Oct 13, and still 1% under its Oct 12 close.
- No company news in our sources;
1 more reason, free with an account →How the business stands, the timeline, and its peers, for Pro members.
Revolution Medicines (RVMD) stock
Close
$188.17
Quality Score
5
In its industry
#66of 291
RVMD's Quality Score fell 1 point on Fri, Oct 30, to 5. Made no higher high and higher low (2 chart checks stopped).
Follow RVMD's trial news. Pro members can get an alert when Revolution Medicines files news, and see its trials, share raises, and its CEO's filings.
Get an alert when RVMD files news on its trialsSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
NextQ4 2026“…clinical data and additional visibility into its CRC development strategy during the fourth quarter of 2026…”
Cash$3.9B, about 12 quarters (3 years) at the last year's spending
Key facts on RVMD
| Holding it back | A $1.1B loss |
| Latest filing | 8-K, Oct 13 |
1 more reason behind RVMD's 5, free with an account →4 more reasons behind RVMD's 5, for Pro members.
RVMD in the news
ReportReports Wednesday, after the close. Every 3 months, a company tells everyone how much it sold and earned. It rose after 2 and fell after 2 of its last 4 reports, -0.8% on average. Past reports ›
What's next
Tue Nov 10: Guggenheim 3rd Annual Global…Investor conference · date confirmed.
1 more date ahead: the conference, for Pro members.
Cash$3.9B, about 12 quarters (3 years) at the last year's spending
RVMD catalysts
Coming up
After its last 4 reports it closed -0.8% on average, higher 2 of 4 times.
2 more coming up and 18 past catalysts since 2022, with sizes and sources, for Pro members.Get in free →
What's next for RVMD, and how long its cash lasts
Next step the company has named
Q4 2026“The company expects to provide updated clinical data and additional visibility into its CRC development strategy during the fourth quarter of 2026.”
Cash runway
About 12 quarters
Dilution on the horizon
- Shelf registration (S-3ASR, filed Mar 4, 2024)
- At-the-market share sales program (424B5, filed Feb 25, 2026)
Insiders
An officer, Anthony Mancini, sold 2,310 shares on Oct 26, under a planned sale. 42 more insider trades this year.
FDA dates in the next 60 days
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
DateStockDrug
- In 20 days
CAPRCapricor Therapeutics
- In 20 days
SVRASavara
- In 50 days
MLYSMineralys Therapeutics
Why RVMD scores 5
Below Averagefor quality, not price, 3 of 14 chart checks firingWhat the Quality Score means
- +3Chart checks 3 of 14 firing right now, one point each
- +2Long-term trend above a rising 200-day average
- Run-up adds
- Size adds
- Profit subtracts
- Dilution subtracts
- Cash flow subtracts
What every line is worth, and the reason behind it, on RVMD and every other stock.Get in free →
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
RVMD has 3 of 14 chart checks firing
The other 10 checks on RVMD, and all 14 on every stock.Get in free →
RVMD RSI today: 45.9, below its 50-day, above its 200-day
- RSI 1445.9
- MACD (12, 26, 9)Above signal
- 50-day average$198.80
- 200-day average$156.36
- 50/200 crossGolden cross
- ADX 1417.8
- Support$180.49
- Resistance$193.82
- 52-week high$224.31
- 52-week low$56.66
- Chart patternFalling channel
- Bollinger Bands (20, 2)Inside
- Volume0.7x
The deep dive on RVMD
- What it does and how it makes moneySEC filing · Feb 25, 2026
- Where it standsSEC filing · Apr 15, 2026
- Who holds and trades it
- Against its closest peers
7 more findings on RVMD, each with its source, for Pro membersGet in free →
How RVMD ranks in Biotech
RVMD is #66 of 291 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 66 |
Cash and short-term investments: RVMD $3.94B, KYMR $691M, NBIX $390M, HALO $231M.
When does RVMD report earnings, and what happens after?
Reports Wed Nov 4, after the close (in 2 days). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
What RVMD reported on Aug 5, 2026
The quarter
The figures are not read from the release yet.
“The increase was primarily driven by higher clinical trial and manufacturing expenses for daraxonrasib and zoldonrasib, increased personnel-related costs due to additional headcount, and higher stock-based compensation expense related to changes in retirement provisions for equity awards and increased headcount.”
Where the sales came from
RVMD's results filing gives no sales by line in a table we read.
The outlook
| Measure | Figure |
|---|---|
| GAAP operating expense | $2.1B to $2.2B |
In the company's words
“The increase was primarily driven by higher stock-based compensation expense related to changes in retirement provisions for equity awards and increased headcount, higher personnel-related costs associated with additional headcount, increased commercial preparation activities, and higher administrative costs.”
From its results filing (SEC filing · Aug 5)
The numbers
- $41B
- today
- $0
- last fiscal year
- $1.1B
- last fiscal year
- -$914M
- last fiscal year
The whole report on RVMD: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.Get in free →
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 5, 2026 | +0.2% | +0.3% | +4.0% |
| May 6, 2026 | -1.5% | -5.7% | -0.8% |
| Feb 25, 2026 | -7.5% | -1.1% | -2.0% |
RVMD sales and profit by year
Sales grew in two of the last seven years, to $0 in 2025. It lost money in each of the eight years.
Insiders trading RVMD
RVMD insider trades
One insider sold $720K across 1 filing in the last 6 months. No open-market buys on record. The newest:
SellAnthony Mancini$720K
RVMD trades by Congress and the executive branch
4 trades disclosed in the last six months. The newest:
SellScott Kupor$1K to $15K
All 4 trades on RVMD disclosed by Congress and the executive branch, for Pro members.Get in free →
RVMD's officers and directors
Officers and directors with a Form 4 in the last 12 months.
Which ETFs hold RVMD?
In ETFs: RVMD is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
About Revolution Medicines
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
What Revolution Medicines says it competes with
“The biotechnology and pharmaceutical industries, and the oncology sector in particular, are characterized by rapid evolution of technologies, fierce competition and strong defense of intellectual property rights.”
2 more sentences and what it says it does, for Pro membersGet in free →
RVMD's score card
Pro members see every line of every stock's score.
- What would turn RVMD's score around: 6 things
- 9 more filings explained, a plain line each
- Real-time prices, no delay
BreakawaySep 22Donald Trump bought RVMD
Straight Answers
Is RVMD a good stock to buy? What its Quality Score says
RVMD scores 5 today, which Breakaway calls Below Average. It is #66 of 291 in Biotech by Quality Score, with 3 of 14 chart checks firing. Down 3% on Oct 13, and still 1% under its Oct 12 close. Cash lasts about 12 quarters at its spending (to Jun 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
What is RVMD's Quality Score?
RVMD scores 5 today, which Breakaway calls Below Average (0 to 5). That is #66 of 291 in Biotech by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind RVMD's 5.
Are insiders buying RVMD?
One insider sold $720K across 1 filing in the last 6 months. No open-market buys on record. The newest is Anthony Mancini, Insider, who sold $720K on Jun 16.
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.